Drospirenone/Ethinyl Estradiol 3 Mg/20 &Micro;g (24/4 Day Regimen): Hormonal Contraceptive Choices &Ndash; Use of a Fourth-Generation Progestin
Patient Preference and Adherence - New Zealand
doi 10.2147/ppa.s3901
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2009
Authors
Publisher
Informa UK Limited